Immuno Oncology Assays Market Size, Share, And Growth Report 2032

Immuno Oncology Assays Market: Size

The global Immuno Oncology Assays Market size was worth around USD 5.15 billion in 2023 and is predicted to grow to around USD 12.74 billion by 2032 with a compound annual growth rate (CAGR) of roughly 10.6% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Immuno Oncology Assays Market on a global and regional level.

Request Free Sample

Immuno Oncology Assays Market: Overview

Immuno-oncology deals with investigating the body’s immune system in response to cancer cells. Immuno-oncology assays are in-vitro assays that are used to study a drug’s or compound’s response in a tumor’s microenvironment. Critical information is obtained with optimized cell-based assays to validate the efficacy of a drug/compound. Immuno oncology assays play an important role in clinical diagnostics of cancer and drug discovery applications.

The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb). Additionally, the rising levels of cancer awareness and the increasing number of government initiatives and funding for early cancer diagnosis research are propelling the immuno oncology assays market growth. However, huge capital investments and high immunotherapy treatment cost may restrain the immuno oncology assays market development. Replacement of chemotherapy with immunotherapy as the first line of therapy and emerging markets may bring new opportunities in the immuno oncology assays market in the future.

Request Free Sample

Immuno Oncology Assays Market: Segmentation

The study provides a decisive view of the immuno oncology assays market by segmenting it based on product, assay, technology, indication, application, and region.

By product, the market includes consumables (reagents and kits, various accessories, etc.) and software.

By assay, the market includes cell migration and invasion, cell proliferation, immune cell killing, phagocytosis, and others. Based on technology, the market includes polymerase chain reaction (PCR), immunoassay, flow cytometry, next-generation sequencing (NGS), and others.

Based on indication, the market includes colorectal cancer, lung cancer, bladder cancer, melanoma, and other cancers.

By application, global immuno oncology assays market is segmented into research applications and clinical diagnostics.

Immuno Oncology Assays Market: Report Scope

Immuno Oncology Assays Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

North America dominated the global immuno oncology assays market with a revenue share of almost 40% in 2023. This huge revenue share is accredited to the increasing prevalence of cancer, the presence of advanced healthcare infrastructure, and rising adoption of targeted therapy. North America is estimated to remain at the top market position over the forecast time period as well, owing to the increasing public and private funding for various R&D activities. Europe contributed the second largest revenue share in 2023 to the global immuno oncology assays market, due to rising cancer burden, growing adoption of technologically advanced products, and increasing healthcare spending. The Asia Pacific immuno oncology assays market will register the highest CAGR in the years ahead, owing to the increasing aging population base, rising cancer prevalence, and ongoing cancer therapy clinical trials.

Immuno Oncology Assays Market: Competitive Players

Some major players operating in the global immuno oncology assays market include:

• Thermo Fisher Scientific
• Agilent Technologies
• Roche Diagnostics
• Nanostring Technologies
• Illumina
• Foundation Medicine
• Sartorius
• Qiagen
• HTG Molecular Diagnostics
• PerkinElmer
• Merck

The Global Immuno Oncology Assays Market is segmented as follows:

Global Immuno Oncology Assays Market: By Product

• Consumables
• Software

Global Immuno Oncology Assays Market: By Assay

• Cell Proliferation
• Cell Migration and Invasion
• Phagocytosis
• Immune Cell Killing
• Other

Global Immuno Oncology Assays Market: By Technology

• PCR
• Immunoassay
• NGS
• Flow Cytometry
• Others

Global Immuno Oncology Assays Market: By Indication

• Lung Cancer
• Colorectal Cancer
• Melanoma
• Bladder Cancer
• Other Cancers

Global Immuno Oncology Assays Market: By Application

• Research Applications
• Clinical Diagnostics

Global Immuno Oncology Assays Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa